Regression analysis of ordinal stroke clinical trial outcomes: An application to the NINDS t-PA trial

International Journal of Stroke

Volumn 9, Issue 2, 2014, Pages 226-231

  Desantis, Stacia M ^a   Lazaridis, Christos ^b   Palesch, Yuko ^a   Ramakrishnan, Viswanathan ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Clinical trial; Modified Rankin scale; Ordinal regression; Partial proportional odds; Proportional odds; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CEREBROVASCULAR ACCIDENT; ERROR; HUMAN; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RANKIN SCALE; REGRESSION ANALYSIS; STATISTICAL MODEL;

CLINICAL TRIAL; MODIFIED RANKIN SCALE; ORDINAL REGRESSION; PARTIAL PROPORTIONAL ODDS; PROPORTIONAL ODDS; TISSUE PLASMINOGEN ACTIVATOR;

CLINICAL TRIALS AS TOPIC; HUMANS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; ODDS RATIO; REGRESSION ANALYSIS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES;

EID: 84892827879     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12052     Document Type: Article

References (29)

1. Bath PMW, Lees KR, Schellinger PD etal. Statistical analysis of the primary outcome in acute stroke trials. Stroke 2012; 43:1171-1178.
2. Tilley BC. Contemporary outcome measures in acute stroke research. Stroke 2012; 43:935-937.
3. Lees KR, Bath PMW, Schellinger PD etal. Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke 2012; 43:1163-1170.
4. The Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? Statistical re-analysis of functional outcomes in stroke trials. Stroke 2007; 38:1911-1915.
5. Brown DL, Coffey CS. Stroke trials: a shift to shift analysis? Neurology 2009; 72:1292-1293.
6. Saver JL, Gornbein J. Treatment effects for which shift or binary analyses are advantageous in acute stroke trials. Neurology 2009; 72:1310-1315.
7. Peterson B, Harrell FE. Partial proportional odds models for ordinal response variables. Appl Stat 1990; 39:205-217.
8. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute stroke. N Engl J Med 1995; 333:1581-1587.
9. Lees KR, Zivin JA, Ashwood T etal. NXY-059 for acute ischemic stroke. N Engl J Med 2006; 354:588-600.
10. Diener HC, Lees KR, Lyden P etal. NYX-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials. Stroke 2008; 39:1751-1758.
11. Howard G, Waller JL, Voeks JH etal. A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke 2012; 43:664-669.
12. Agresti A. Categorical Data Analysis, 2nd edn. John Wiley & Sons, Inc., Hoboken, NJ, Wiley, 1990.
13. Agresti A. Analysis of Ordinal Categorical Data, 2nd edn. John Wiley & Sons, Inc., Hoboken, NJ, Wiley, 2010.
14. Agresti A. Examples of Using R for Modeling Ordinal Data, Supplement for Analysis of Ordinal Categorical Data, 2nd edn. John Wiley & Sons, Inc., Hoboken, NJ, Wiley, 2010.
15. Tilley B, Marler J, Geller N etal. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke tPA trial. Stroke 1996; 27:2136-2142.
16. Rao CR. Large sample tests of statistical hypotheses concerning several parameters with application to problems of estimation. Proc Camb Phil Soc 1973; 44:50-57.
17. McCullagh P. Regression models for ordinal data (with Discussion). JRRS B 1980; 42:109-142.
18. Bender R, Grouven U. Using binary logistic regression models for ordinal data with non-proportional odds. J Clin Epidemiol 1998; 51:809-816.
19. Li N, Elashoff RM, Li G, Saver J. Joint modeling of longitudinal ordinal data and competing risks survival times and analysis of the NINDS rtPA stroke trial. Stat Med 2010; 29:546-557.
20. Murray GD, Barer D, Choi S etal. Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy. J Neurotrauma 2005; 22:511-517.
21. Wardlaw J, Sandercock P, Warlow C, Lindley RI. Trials of thrombolysis in acute ischemic stroke: does the choice of primary outcome measure really matter? Stroke 2000; 31:1133-1135.
22. Scott SC, Goldberg MS, Mayo NE. Statistical assessment of ordinal outcomes in comparative studies. J Clin Epidemiol 1997; 50:45-55.
23. Liu I, Mukherjee B, Suesse T, Sparrow D, Park SK. Graphical diagnostics to check model misspecification for the proportional odds regression model. Stat Med 2009; 28:412-429.
24. Kwiatowski TG, Libman RB, Frankel M etal. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 1999; 340:1781-1787.
25. del Zoppo GJ, Poeck K, Pessin MS etal. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32:78-86.
26. Mwalili SM, Lesaffre E Declerck D. A Bayesian ordinal logistic regression model to correct for interobserver measurement error in a geographic oral health study. App Stat 2005; 54:77-93.
27. Shirkey BA. 2009). An ordinal logistic regression model with misclassification of the outcome variable and categorical covariate. ProQuest, University of Texas School of Public Health Dissertation.
28. Whitehead J. Sample size calculations for ordered categorical data. Stat Med 1993; 12:2257-2271 [published erratum appears in Stat Med 1994; 13 (8): 871].
29. Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995; 311:1145-1148.